Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life-Reference-Cited by-同舟云学术

Systematic review with network meta-analysis: the impact of medical interventions for moderate-to-severe ulcerative colitis on health-related quality of life

Published:2018-10-30 Issue:11-12 Volume:48 Page:1174-1185
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Paschos Paschalis¹²^ORCID,Katsoula Anastasia¹^ORCID,Salanti Georgia³,Giouleme Olga⁴,Athanasiadou Eleni¹,Tsapas Apostolos¹⁵

Affiliation:

1. Clinical Research and Evidence-Based Medicine Unit; Second Medical Department; Aristotle University of Thessaloniki; Thessaloniki Greece

2. First Department of Internal Medicine; “Papageorgiou” Hospital; Thessaloniki Greece

3. Institute of Social and Preventive Medicine & Clinical Trials Unit; University of Bern; Bern Switzerland

4. Second Propaedeutic Department of Internal Medicine; Aristotle University of Thessaloniki; Thessaloniki Greece

5. Harris Manchester College; University of Oxford; Oxford UK

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.15005/fullpdf

Reference43 articles.

1. Third European Evidence-Based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders;Magro;J Crohns Colitis,2017

2. Food and Drug Administration Ulcerative Colitis: Clinical Trial Endpoints Guidance for Industry 2016 https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM515143.pdf

3. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target;Peyrin-Biroulet;Am J Gastroenterol,2015

4. The impact of biological interventions for ulcerative colitis on health-related quality of life;LeBlanc;Cochrane Database Syst Rev,2015

5. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool;Salanti;Res Synth Methods,2012

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coptisine alleviates colitis through modulating gut microbiota and inhibiting TXNIP/NLRP3 inflammasome;Journal of Ethnopharmacology;2024-12

2. National 30-Day Readmission Trends in IBD 2014–2020—Are We Aiming for Improvement?;Medicina;2024-08-13

3. Network meta‐analysis: Comparative onset of early effect of biologics and small molecules in moderately to severely active luminal Crohn's disease;Alimentary Pharmacology & Therapeutics;2024-06-11

4. Cost per Number Needed to Treat (NNT) for upadacitinib in the treatment of bio-exposed patients with moderately-severely active ulcerative rectocolitis;Global and Regional Health Technology Assessment;2024-03-07

5. Economic evaluation of two therapeutic sequences in the first-line treatment of moderate to severe active ulcerative rectocolitis in Italy;AboutOpen;2024-03-02